Use of protease inhibitors among persons with AIDS in Los Angeles County

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 11, Issue 2, 1999, Pages 147-155

  Sorvillo, Frank ^a   Kerndt, P ^a   Odem, S ^a   Castillon, M ^a   Carruth, A ^a   Contreras, R ^a  

^a LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUCASIAN; EDUCATION; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; INCOME; INTERVIEW; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; TIME; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INSURANCE, HEALTH; LOS ANGELES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 0033005916     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540129948045     Document Type: Article

References (29)

1. AUTRAN, B., CARCELAIN, G., LI, T.S. et al. (1997). Positive effects of combined antiretroviral therapy on CD4 + T cell homeostasis and function in advanced HIV care. Science, 277, 112-116.
2. BARRON, W.M. (1980). Failed appointments. Who misses them, why they are missed, and what can be done. Primary Care, 4, 563-574.
3. BRAVEMAN, P., BENNT, T., LEWIS, C. et al. (1993). Access to prenatal care following major Medicaid eligibility expansions. Journal of the American Medical Association, 269, 1285-1289.
4. BRAVEMAN, P., SCHAAF, V.M., EGERTER, S. et al. (1994). Insurance-related differences in the risk of ruptured appendix. New England Journal of Medicine, 331, 444-449.
5. CARPENTER, C.C.J., FISCHL, M.A., HAMMER, S.M. et al. (1997). Antiretroviral therapy for HIV infection in 1997. Journal of the American Medical Association, 277, 1962-1969.
6. COLLIER, A.C., COOMBS, R.W., SCHOENFELD, D.A. et al. (1996). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. AIDS Clinical Trials Group. New England Journal of Medicine, 334, 1011-1017.
7. CUNNINHAM, W.E., HAYS, R.D., WILLIAMS, K.W. et al. (1995). Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Medical Care, 33, 739-754.
8. DANNER, S.A., CARR, A., LEONARD, J.M. et al. (1995). A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitory of HIV-1 protease. New England Journal of Medicine, 333, 1528-1533.
9. DIAZ, T., CHU, S.Y., BYERS, R.H. et al. (1994). The types of drugs used by HIV-infected injection drug users in a multistage surveillance project: implications for intervention. American Journal of Public Health, 84, 1971-1975.
10. EHMKE, D.A., STEHBENS, J.A. & YOUNG, L. (1980). Two studies of compliance with daily prophylaxis in rheumatic fever patients in Iowa. American Journal of Public Health, 70, 1189-1193.
11. GRAHAM, N.M., JACOBSON, L.O., KUO, V. et al. (1994). Access to therapy in the Multicenter AIDS Cohort Study, 1989-1992. Journal of Clinical Epidemiology, 47, 1003-1012.
12. GREENLAND, S. (1989). Modeling and variable selection in epidemiologic analysis. American Journal of Public Health, 79, 340-349.
13. GREENLAND, S., LIEB, L., SIMON, P. et al. (1996). Evidence for recent growth of the HIV epidemic among African- American men and younger male cohorts in Los Angeles County. Journal of the Acquired Immune Deficiency Syndrome, 11, 401-409.
14. GUPTA, P., MELLORS, J., KINGSLEY, L. et al. (1997). High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. Journal of Virology, 71, 6271-6275.
15. HAYWARD, R.A., SHAPIRO, M.F., FREEMAN, H.E. & COREY, C.R. (1988). Inequities in health services among insured Americans. Do working-age adults have less access to medical care than the elderly? New England Journal of Medicine, 318, 1507-1512.
16. HORNER, R.D., BEUNT, C.L., RODRIGUEZ, D. et al. (1995). Relationship between procedures and health insurance for critically ill patients with Pneumocystic carinii pneumonia. American Journal of Respiratory Critical Care Medicine, 152, 1435-1442.
17. HOSMER, D.W. & LEMESHOW, S. (1989). Applied logistic regression. New York: John Wiley.
18. JACOBSEN, H., HANGGI, M., OTT, M. et al. (1996). In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics and frequencies. Journal of Infectious Diseases, 173, 1379-1387.
19. KIEFE, C.I., MCKAY, S.V., HALEVY, A. & BRODY, B.A. (1994). Is cost a barrier to screening mammography for low-income women receiving Medicare benefits? A randomized trial. Archives of Internal Medicine, 11, 1271-1224.
20. MARKOWITZ, M., SAAG, M., POWDERLY, W.G. et al. (1995). A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. New England Journal of Medicine, 333, 1534-1539./
21. MICKEY, M.R. & GREENLAND, S. (1989). A study of the impact of confounder-selection criteria on effect estimation. American Journal of Epidemiology, 129, 125-137.
22. MOORE, P. & HEPWORTH, J.T. (1994). Use of perinatal and infant health services by Mexican-American Medicaid enrollees. Journal of the American Medical Association, 272, 297-304.
23. MOORE, R.D., STANTON, D., GAPOLAN, R. & CHAISSON, R.E. (1994). Racial differences in the use of drug therapy for HIV disease in an urban community. New England Journal of Medicine, 330, 763-768.
24. PALELIA, F.J., JR., DELANEY, K.M., MOORMAN, A.C. et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860.
25. ROTHMAN, K. & GREENLAND, S. (1998). Modern epidemiology. Philadelphia: Lippincott-Raven.
26. SIMON, P., SORVILLO, F. & LAPIN, R. (1994). Racial differences in the use of drug therapy for HIV disease [letter]. New England Journal of Medicine, 330, 763-768.
27. SOLOMON, L., STEIN, M., FLYNN, C. et al. (1998). Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 17, 253-261.
28. SORVILLO, F.J., KERNDT, P., CHENG, K.-J. et al. (1995). Emerging patterns of HIV transmission: the value of alternative surveillance methods. AIDS, 9, 625-629.
29. VANHOVE, G.F., SCHAPIRO, J.M., WINTERS, M.A. et al. (1996). Patient compliance and drug failure in protease inhibitor monotherapy. Journal of the American Medical Association, 276, 1955-1956.